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In trials attempts to study the biochemical
effects of the psoralen derivatives (ammoidin,
8-methoxypsoralen) and ammidin (5-iso amylene
psoralen) on the two very important factors
controlling tyrosinase activity (the concentration
and the availability of copper and glutathione),
it has been found that the oral administration
of the drugs caused a rise in the level of sermn
copper (1). The drugs used are given in thera-
peutic doses of 0.7 mgm/Kg. body weight di-
vided in 3 doses; and the rise in the level of
serum copper was found to be about 50 micro-
gram/l00 ml. serum.
In another study (2) exploring the mode of
action of psoralen compounds on blood and
tissue copper contents, it has been found that
doses of 800 mg. ammoidin 1Kg. body weight
in short experiments or 300 mg./Kg. body
weight in longer experiments on albino rats over
a period of 16 days caused a dramatic increase in
the level of serum copper and a marked reduction
in the liver copper content. The blood levels were
enormously raised in the short experiments from
the normal mean value of 131 microgram/100 ml.
serum up to an average of 325 microgram! 100 ml.
serum up to an average of 341 microgram in the
prolonged experiments. The levels of copper
content of the liver were markedly lowered from
the normal average of 115 down to 65.3 in the
short experimentation and to 97 microgram/100
gram fresh weight in the longer experiments.
On the other hand, the administration of
ammidin in the same doses and under the same
experimental conditions has proved to have no
effect.
However, the mechanism by which this effect
on copper mobilization is achieved is not yet
determined.
it is well known that certain hyperpigmentary
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conditions are governed by or may be due to one
or another hormonal disturbance.
The activity of the melano-stimulating hor-
mone of the pituitary (M.S.H.) has been sug-
gested to be the cause of increase in serum
copper and hence activates skin tyrosinase (3, 4).
The injections of large amounts of M.S.H.
has been reported to produce generalized mel-
anosis (5), whereas local M.S.H. injections have
no direct effect in stimulation of pigmentation
in vitiiginous areas (6). Furthermore, it has been
suggested that the Addisonian type of melanosis
occasionally accompanying the administration
of A. C. T. H. in man, may result from the high
M. S. H. activity of such preparations (7).
It has also been reported by Hall, McCracken
and Thorn (8), on the basis of reflectance spectro-
photometric studies, that cortisone generally
caused a decrease in skin melanin content, where-
as A.C.T.H. causes an increase. It has also been
reported by Lorincz (9) that cortisone is not
pigmentogenic. However it has been stated (10)
that cortisone administration results in melanosis.
Moreover adrenalectomy has been found to have
a pigment restorative effect which can be counter-
acted by desoxycorticosterone (11, 12, 13). The
inhibition of the adrenal cortical hormones on
pigmentation has also been reported by many
workers (14, 15). It was thought, therefore, to
be of value and interest to attempt to clarify
this problem by studying the effect of hypophy-
sectomy, adrenalectomy, A.C.T.H. and cor-
tisone either alone or in combination with the
administration of ammoidin on both serum and
tissues copper and glutathione contents.
EXPERIMENTAL
Albino rats (weight from 150—200 gm) were used
in this work.
In our experimentation on hypophysectomized
rats the animals were divided into two groups. The
first group was given the drug ammoidin (8-meth-
oxy psoralen) in doses of 800 mg./Kg. body weight
and the second group did not receive the drug. A
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group of normal non-operated rats was used to
serve as control for the previous two groups. The
dose of 800 mg. of ammoidin/Kg. body weight was
used, since it gave in our hands (2) a rise in serum
copper from 217 to 403 microgram with a mean
value of 325 microgram per cent as compared to
the normal value of serum copper in albino rats
which varies from 122—140 microgram per cent with
a mean value of 131 microgram per cent.
The hypophysectomized rats were divided into
two groups the first group was given the drug
(ammoidin) and the second group of rats was left
as control.
Bilateral adrenalectomy for another group of
rats was carried out.
After operation the rats were maintained on the
laboratory diet plus 5% glucose and 1% saline
solution. The adrenalectomized rats were divided
into two groups. The rats of the first group were
given the drug in the mentioned dose on two suc-
cessive days orally mixed with food forced fed with
a polythane tube attached to a sryinge. The second
group of adrenalectomized rats was not given the
drug and used as control. The rats were all sacri-
ficed by decapitation and blood collected from the
neck for the estimation of its copper and gluta-
thione contents. The rats were also dissected and
parts of tissues (liver, spleen, kidney) rapidly re-
moved, washed in physiological saline, blotted on
filter paper to remove extra fluid, weighed and
kept in the deep freeze till time of analysis for
finding out their copper and glutathione content.
The blood copper was estimated by the method
of Gubler et at. (18).
The same method was adopted for the estima-
tion of tissue copper content after the latter being
homogenized in physiological saline solution (2).
RESULTS
The results obtained for the hypophy-
sectomized animals receiving ammoidin and
their controls are shown in Table I.
The mean value for serum and liver copper
TABLE I
Tissue Analyzed
Mode of Experimentation
Hypophysectomy
Hypophy-
sectomv
Ammoiclin Normal
mean
Serum Copper
Liver Copper
I 2 3 mean
196L86L82188
121111811351125
I
1 2 I
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150L701160
12911221125
value
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Tissue Analyzed
Mode of Experimentation
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Normal
rats
recewsng
mmoidin
Hypophy-
Se!tO-
mized
Hypophy-
secto-
mixed +
Ammoidin
Serum Copper
Liver Copper
122
110
325
63.5
160
125
188
125
contents of the normal rats receiving no drug
and the normal rats receiving ammoidin compared
to the results obtained for hypophysectomized
rats receiving ammoidin and hypophysectomized
rats with no drug are given in Table II.
These findings show that ammoidin when given
in doses of 800 mgm/Kg B.W. to normal rats
caused a great increase in the serum copper and
a marked decrease in the level of the liver copper
content, whereas when given to hypophy-
sectomized animals it caused no change in either
serum or liver copper contents. Also bypophy-
seetomy alone without giving the drug ammoidin
caused no change in the copper content of either
blood or liver. However, although the levels of
copper in both the blood and liver of the hypophy-
sectomized animals in the two groups are slightly
higher than the normal mean value, yet in our
hands some animals which were completely
normal and not treated with any drug gave values
of 150 microgram of copper in blood. The differ-
ence of 20-40 microgram% in the hypophy-
sectomized animals may be attributed to dehy-
dration which was observed in the animals. The
results obtained for these hypophysectomized
animals are graphically represented in Fig. 1.
Again the removal of the pituitary, prevents,
the occurrence of any rise in blood copper on the
administration of ammoidin, since as shown in
Table II the latter compound causes a rise in
blood copper up to 325 microgram in average
(2). This shows that the mechanism of mobi-
lization of liver copper in the blood on the
administration of ammoidin is taken place
through the pituitary. The nature of this action
of ammoidin was felt to need further explanation.
In an attempt to elucidate this point, experiments
have been carried out to study the effect of
A.C.T.H. preparations, the effect of adren-
alectomy and the effect of cortisone on the
mechanism of copper mobilization.
TABLE II
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I. Effect of A.C.T.H. administration
A.O.T.H. (Organon) was adminstered in doses
of 10 i.u. per/day/rat for a period of 16 days. In
a group of rats the administration of the hormone
was supplemented by the oral intake of aminoidin
in doses of 800 mg./Kg. B.W. The results obtained
from these two groups of rats receiving A.C.T.H.
with and without ammoidin are graphically
represented in Fig. 2.
The figures obtained for individual experi-
mental animals are given in Table III.
These figures in Table III show that the
administration of A.C.T.H. caused a marked
degree of mobilization of copper from the liver
to blood, since the level of blood copper was
raised from a normal mean value of 131 micro-
gram % to 282 microgram % and the level of
liver copper was decreased from a normal average
of 115 microgram% to 73 microgram %. In
animals receiving both A.C.T.H. and ammoidin
the mobilization of copper from the liver to the
blood was enormous. The blood copper level
reached an average of 403 microgram % and the
liver content fell to 49 microgram %.
II. Effect of adreno2ectomy
The results obtained for the copper content
of liver and blood of adrenalectomized animals
are given in Table IV and graphically represented
in Fig. 3.
The data obtained were very interesting. The
figures for copper content of the liver and blood
in adrenalectomized rats receiving ammoidin
showed marked mobilization of the copper from
liver to the blood. A rise in copper of the blood
from the normal 131 microgram/100 ml serum to
262 microgram/100 was found and a parallel
drop in the liver copper from the normal 115
microgram% to 35 microgram% was observed.
This mobilization is comparable to that obtained
with pituitary stimulation by administration of
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Fio. 1. Effect of hypophysectomy on copper levels
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TABLE III
ammoidin and also with the results obtained in
A.C.T.H.—treated rats. In adrenalectomized
animals given ammoidin the mobilization of the
copper from the liver to the blood was even more
marked. The rise in the blood was from 131
microgram! 100 mL serum to 302 microgram% and
the drop in liver content from an average of 115
microgram % to a mean value of 28 microgram.
This latter figure for liver copper was the lowest
figure ever obtained in our hands.
III. Effect of cortisone administration
2 groups of rats were given cortisone (Ciba)
intramuscularly in 5 mg./rat/day for 16
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Tissue Analysis
A.C.T.H. Alone A.C.T.H. ÷ Ammoidin
1 2 3 4 5 6 mean 1 2 3 4 mean
Serum Copper
Liver Copper
281 282 282 275
101.4 48.4 69.8 56.4
286 288 283
75.8 86.8 73
407 399 401 405 403
49.6 48.4 74.2 50.8 49
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Tissue Analysis
Mode of Experiment
Adrenalectomjzed + Ainsnoidin Adrenalectomized
1 2 3 4 mean 1 2 3 4 mean
Serum Copper
Liver Copper
324 380 284 320
22 33.6 24 32.4
302
28
294 231 273 250
29.4 40.8 32 37.8
262
35
320
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180
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80
60
40
20
0
FIG. 3. Effect of adrenalectomy on copper levels
TABLE V
Tissue Analysis
Mode of Experimentation
Cortisone Alone Cortisone + Aminoidin
1 2 3 4 5 6 7 mean 1 2 3
385 234 242 260 280
74 65 58 62 58
Serum Copper
Liver Copper
111 131 80 115 168 112 120 128
179 152 160 84 105 103 112 149
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successive days, one of these received ammoidin
in addition and the other received cortisone alone.
The result obtained for the serum and liver
copper contents are given in Table V and graphi-
cally represented in Fig. 4.
Thus it was found that rats received cortisone
alone showed no rise in serum copper content
and on the contrary in some rats cortisone caused
a significant drop in copper blood levels together
with slight increase in the liver copper level. On
the other hand, the administration of ammoidin
together with cortisone caused a marked elevation
in serum copper content from a normal mean
value of 131 microgram per cent to an average
value of 280 microgram%. The liver copper
content dropped from 115 microgram to a mean
value of 58 microgram in the last group.
DISCUSSION
It has been shown in a previous paper that
rats receiving ammoidin show remarkable mobi-
lization of copper from liver to blood, strongly
suggesting that this effect of psoralen (increasing
the copper content of blood) might be its main
mode of action in promoting pigmentation and
melanin formation. In the present work, this
effect of ammoidin was further explored, while
studing the effect of hypophysectomy, adren-
alectomy, A.C.T.H. and cortisone administration
with and without ammoidin administration. It
was clear to us that not only the mode of action
of ammoidin was elucidated, but very interesting
facts related to endocrine control of copper
metabolism were brought to light. Ammoidin
mobilizes copper from liver to blood. Hypophy-
sectomy abolishes the effect of ammoidin, i.e.
ammoidin to have a mobilizing effect on copper
from liver to blood the pituitary gland must be
intact. Hypophysectomy alone has no effect on
the level of copper in blood or liver. This suggests
that the action of pituitary on copper mobi-
lization is not continuous effect, but is rather an
action which is initiated by certain stimuli.
A.C.T.H. administration was found to cause
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marked mobilization of copper from liver to
blood up to 282 microgram% in blood and down
to 73 microgram% in the liver. Whether this
effect is due to A.C.T.H. or to an impurity of
M.S.H. is not clear. It is well known tht sepa-
ration of M.S.H. from A.C.T.H. without loss of
either activity has not been accomplished and
that the most highly purified A.C.T.H. prepa-
rations have high M.S.H. activity (9).
In our hands, ammoidin administration in man,
while causing rise in blood copper, did not lead
to a rise of 17 ketosteroids in urine (under publi-
cation). This dissociated effect suggests that
ammoidin action on the pituitary is mainly
through M.S.H. rather than A.C.T.II..
In the group of rats receiving A.C.T.H.
(Organon) and ammoidin the mobilization of
copper was enormous (up to 403 microgram% in
blood and down to 49 microgram % in the liver).
This could be explained by sum of the effects of
pituitary hormone administered from without
and pituitary stimulation by ammoidin.
It was thought advisable to find out whether
or not this pituitary effect was mediated through
the adrenals. The results were very interesting.
Adrenalectomy alone caused mobilization of
copper almost comparable with ammoidin
administration, i. e. pituitary stimulation or
A.C.T.H. administration. These results clearly
show that the adrenals are normally exercising a
restraining effect on the pituitary and preventing
its mobilizing effect of copper (from liver to
blood). When the adrenals were removed, the
liver copper was mobilized to the blood as a
result of freeing the pituitary from the physio-
logical checking mechanism of the adrenals. A
further rise was obtained when the pituitary was
stimulated by the administration of ammoidin.
Moreover, the administration of the cortisone
alone was found to be of no effect on both serum
and liver copper content. On its administration
in combination with ammoidin, the latter com-
pound manifested its stimulating effect on the
pituitary causing mobilization of copper from the
liver to the blood. Thus, we can say that the
pituitary under certain stimulations can have a
powerful mobilizing effect on the copper from
liver to blood by secretion of M.S.H. This effect
is definitely not mediated through the adrenals.
On the contrary, the adrenals have a physiologic
restraining effect on the pituitary. One of the
strongest stimuli of this pituitary mechanism was
ammoidin administration and to a less extent
adrenalectomy.
POSSIBLE RELATION OF BLOOD COPPER
WITH PIGMENTARY DISORDERS
The role of copper in activation of tyrosinase
has been repeatedly demonstrated. It has been
reported that the presence of copper sulfate in
tyrosinase solution led to a speeding-up of the
reaction in the melanocytes in both freckles and
pale epidermis (26). It is but natural to expect a
reflection of blood copper changes on pigmentary
mechanism. A rise in blood copper might be
expected to have a similar stimulating effect on
melanogenesis. Increased blood copper level has
been reported in the Riehi's melanosis (27, 28).
Hypercupremia has been reported in cases of
leukemia, Hodgkin's disease, Addison's disease
and pregnancy, all of which are known to be asso-
ciated with hyperpigmentation.
With this fact of endocrine control of copper
metabolism one can easily explain the marked
pigmentation in Addison's disease when it is
secondary to adrenal disease, and the lack of pig-
mentation in Addison's disease of pituitary ori-
gin.
In adrenal failure the physiologic restraining
effect on the pituitary is lost and the pituitary
can freely mobilize copper from liver to blood.
it is evident that if the primary fault is in the
pituitary, no such mobilization is expected to
occur.
In a previous paper it was suggested that many
cases of leukoderma appear to be due to general
homeostatic disorders rather than constitute
local cellular changes. To what extent the changes
in blood copper levels are responsible for the type
of leukoderma which is produced by failure of
control mechanisms is not yet clear.
The previously reported effect of psoralens on
stimulating pigmentation and the present finding
that ammoidin has a remarkable hypercupremic
effect makes it highly plausible that the mode of
action of ammoidin in stimulation of melanin
formation is related to its stimulating effect on
blood copper. We feel that it has been firmly
established that ammoidin exerts this effect
through its stimulation of the pituitary. The
raised copper level in turn activates the skin
tyrosinase. This mobilizing effect of the pitui-
tary on copper from the liver to the blood has
been shown to be curtailed by the adrenal.
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SUMMARY
1. Ammoidin causes marked mobffization of
copper from liver to blood in rats.
2. This action of ammoidin is performed
through the pituitary. In its absence, no effect
was obtained.
3. The effect of the pituitary stimulation by
ammoidin is not mediated through the adrenals,
since this stimulating effect has been shown to
occur in adrenalectomized animals.
4. Adrenalectomy alone caused mobilization
of copper from liver to blood.
5. The adrenals physiologically perform a
restraining effect on the pituitary action on
copper mobilization.
6. A.C.T.H. available preparations, possibly
due to M.S.H. contamination, show a copper
mobilizing effect from liver to blood.
7. Cortisone has no mobilizing action on copper
from liver to blood. In some cases it seemed to
show a stabilizing action, i.e. causing a low blood
copper and rise of liver copper content.
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